Publication:
Hepatic veno-occlusive disease after bone marrow transplantation

dc.contributor.authorsCanpolat C., Basdemir D.
dc.date.accessioned2022-03-28T14:50:10Z
dc.date.accessioned2026-01-11T15:58:26Z
dc.date.available2022-03-28T14:50:10Z
dc.date.issued1996
dc.description.abstractIn the first few weeks after bone marrow transplantation, a clinical syndrome characterized by hepatomegaly, jaundice, and fluid retention develops in 10 to 70% of patients. This syndrome is due to damage to endothelial cells, sinusoids, and hepatocytes in zone 3 of the liver acinus. The proximate cause of the damage is cytoreductive therapy. This syndrome, often called veno-occlusive disease of the liver, can vary in severity from mild reversible disease to fatal disease associated with multiorgan failure.
dc.identifier.issn10191941
dc.identifier.urihttps://hdl.handle.net/11424/255344
dc.language.isoeng
dc.relation.ispartofMarmara Medical Journal
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBone marrow transplantation
dc.subjectCytoreductive therapy
dc.subjectHepatic veno-occlusive disease
dc.titleHepatic veno-occlusive disease after bone marrow transplantation
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage95
oaire.citation.issue2
oaire.citation.startPage89
oaire.citation.titleMarmara Medical Journal
oaire.citation.volume9

Files